These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

165 related items for PubMed ID: 7901181

  • 21. [New chemotherapy approaches to psychoses].
    Olié JP, Baylé FJ.
    Encephale; 1997 Apr; 23 Spec No 2():2-9. PubMed ID: 9273302
    [Abstract] [Full Text] [Related]

  • 22. [New antipsychotic agents: new paths of research on the notion of atypical agents].
    Gosselin O, Di Scala G, Ribeyre JM, Kahn JP.
    Encephale; 1996 Dec; 22 Spec No 6():3-6. PubMed ID: 9102317
    [Abstract] [Full Text] [Related]

  • 23. Zotepine: preclinical tests predict antipsychotic efficacy and an atypical profile.
    Needham PL, Atkinson J, Skill MJ, Heal DJ.
    Psychopharmacol Bull; 1996 Dec; 32(1):123-8. PubMed ID: 8927661
    [Abstract] [Full Text] [Related]

  • 24. Effects of tryptophan and valine administration on behavioral pharmacology of haloperidol.
    Ali O, Haleem DJ, Saify ZS, Kamil N, Obaid R, Ahmed SW.
    Pak J Pharm Sci; 2005 Apr; 18(2):23-8. PubMed ID: 16431394
    [Abstract] [Full Text] [Related]

  • 25. [Two cases of tardive Tourette syndrome].
    Yamauchi K, Ohmori T.
    Seishin Shinkeigaku Zasshi; 2006 Apr; 108(5):459-65. PubMed ID: 16869393
    [Abstract] [Full Text] [Related]

  • 26. Could the interaction of neuroleptics with calmodulin be an "explanation" of the psychotropic effects?
    Lejoyeux M, Maziere JC.
    Encephale; 1991 Apr; 17(1):11-5. PubMed ID: 1688272
    [Abstract] [Full Text] [Related]

  • 27. Neuroleptic treatment effect on mitochondrial electron transport chain: peripheral blood mononuclear cells analysis in psychotic patients.
    Casademont J, Garrabou G, Miró O, López S, Pons A, Bernardo M, Cardellach F.
    J Clin Psychopharmacol; 2007 Jun; 27(3):284-8. PubMed ID: 17502776
    [Abstract] [Full Text] [Related]

  • 28. Differences in the effects of haloperidol and clozapine on brain serotonin and dopamine metabolism and on tests related to extrapyramidal functions in rats.
    Haleem DJ, Batool F, Khan NH, Kamil N, Ali O, Saify ZS, Haleem MA.
    Med Sci Monit; 2002 Sep; 8(9):BR354-61. PubMed ID: 12218936
    [Abstract] [Full Text] [Related]

  • 29. Neuronal basis of neuroleptic-induced extrapyramidal side effects.
    Ossowska K.
    Pol J Pharmacol; 2002 Sep; 54(4):299-312. PubMed ID: 12523484
    [Abstract] [Full Text] [Related]

  • 30. Neuroleptic-induced supersensitivity psychosis: clinical and pharmacologic characteristics.
    Chouinard G, Jones BD.
    Am J Psychiatry; 1980 Jan; 137(1):16-21. PubMed ID: 6101522
    [Abstract] [Full Text] [Related]

  • 31. Changes in extracellular dopamine in the rat globus pallidus induced by typical and atypical antipsychotic drugs.
    Fuchs H, Hauber W.
    Neurochem Int; 2004 Dec; 45(7):1029-38. PubMed ID: 15337302
    [Abstract] [Full Text] [Related]

  • 32. Protective effect of Curcumin, the active principle of turmeric (Curcuma longa) in haloperidol-induced orofacial dyskinesia and associated behavioural, biochemical and neurochemical changes in rat brain.
    Bishnoi M, Chopra K, Kulkarni SK.
    Pharmacol Biochem Behav; 2008 Feb; 88(4):511-22. PubMed ID: 18022680
    [Abstract] [Full Text] [Related]

  • 33. Regional selectivity of neuroleptic drugs: an argument for site specificity.
    Borison RL, Diamond BI.
    Brain Res Bull; 1983 Aug; 11(2):215-8. PubMed ID: 6138135
    [Abstract] [Full Text] [Related]

  • 34. [Action of etmozin and ethacizin on dopaminergic adenylate cyclase of the striate system of the brain].
    Baldenkov GN, Ratner EI, Rozenshtraukh LV, Tkachuk VA.
    Biull Eksp Biol Med; 1984 Oct; 98(10):448-50. PubMed ID: 6149776
    [Abstract] [Full Text] [Related]

  • 35. [Side-effects of neuroleptics].
    Wolf MA, Villeneuve A.
    Encephale; 1990 Oct; 16(2):111-24. PubMed ID: 1972051
    [Abstract] [Full Text] [Related]

  • 36. Dopaminergic supersensitivity after neuroleptics: time-course and specificity.
    Muller P, Seeman P.
    Psychopharmacology (Berl); 1978 Dec 15; 60(1):1-11. PubMed ID: 32574
    [Abstract] [Full Text] [Related]

  • 37. [Neuroleptic malignant syndrome and atypical antipsychotics: a brief review].
    Khaldi S, Kornreich C, Choubani Z, Gourevitch R.
    Encephale; 2008 Dec 15; 34(6):618-24. PubMed ID: 19081460
    [Abstract] [Full Text] [Related]

  • 38. [Neurotensin, dopamine and mode of action of neuroleptics].
    Tassin JP.
    Encephale; 1989 Dec 15; 15(5):465-70. PubMed ID: 2574102
    [Abstract] [Full Text] [Related]

  • 39. Atypical neuroleptics in the treatment of early onset schizophrenia.
    Masi G.
    Panminerva Med; 1997 Sep 15; 39(3):215-21. PubMed ID: 9360425
    [Abstract] [Full Text] [Related]

  • 40. Pharmacologic features and effects of neuroleptics.
    Seeman MV.
    Can Med Assoc J; 1981 Oct 15; 125(8):821-6. PubMed ID: 6118205
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.